ISSN:
eISSN:
Disciplines
(Field of Science):
- biomedical engineering (Engineering and Technology)
- medical biology (Medical and Health Sciences )
- pharmacology and pharmacy (Medical and Health Sciences )
- medical sciences (Medical and Health Sciences )
- health sciences (Medical and Health Sciences )
- family studies (Family studies)
- biotechnology (Natural sciences)
- biological sciences (Natural sciences)
(Field of Science)
Ministry points: Help
Year | Points | List |
---|---|---|
Year 2024 | 140 | Ministry scored journals list 2024 |
Year | Points | List |
---|---|---|
2024 | 140 | Ministry scored journals list 2024 |
2023 | 140 | Ministry Scored Journals List |
2022 | 140 | Ministry Scored Journals List 2019-2022 |
2021 | 140 | Ministry Scored Journals List 2019-2022 |
2020 | 140 | Ministry Scored Journals List 2019-2022 |
2019 | 140 | Ministry Scored Journals List 2019-2022 |
2018 | 35 | A |
2017 | 35 | A |
2016 | 35 | A |
2015 | 35 | A |
2014 | 35 | A |
2013 | 30 | A |
2012 | 30 | A |
2011 | 30 | A |
2010 | 13 | A |
Model:
Points CiteScore:
Year | Points |
---|---|
Year 2023 | 8.7 |
Year | Points |
---|---|
2023 | 8.7 |
2022 | 9.4 |
2021 | 11.7 |
2020 | 10.5 |
2019 | 8.2 |
2018 | 6.6 |
2017 | 5.6 |
2016 | 5.2 |
2015 | 5 |
2014 | 4.9 |
2013 | 4.7 |
2012 | 4.1 |
2011 | 3.5 |
Impact Factor:
Sherpa Romeo:
Papers published in journal
Filters
total: 2
Catalog Journals
Year 2021
-
Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors
PublicationThe aim of this work is review of tacrine analogues from the last three years, which were not included in the latest review work, donepezil and galantamine hybrids from 2015 and rivastigmine derivatives from 2014. In this account we summarize the efforts toward the development and characterization of non-toxic inhibitors of cholinesterases based on mentioned drugs with various interesting additional properties such as antioxidant,...
Year 2019
-
Therapeutic Potential of Multifunctional Tacrine Analogues
PublicationTacrine is a potent inhibitor of cholinesterases (acetylcholinesterase and butyrylcholinesterase) that shows limiting clinical application by liver toxicity. In spite of this, analogues of tacrine are considered as a model inhibitor of cholinesterases in the therapy of Alzheimer’s disease. The interest in these compounds is mainly related to a high variety of their structure and biological properties. In the present review, we...
seen 611 times